The Petri Dish: Two new biotech IPOs and a $450M+ licensing deal
Drugmakers undertook large-scale fundraising efforts this week, including two biotechs with plans to take advantage of the industry's IPO boom.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Allison DeAngelis Source Type: news